Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...
Previous Community Perspectives have described threats posed by Artificial Intelligence (AI) and its convergence with the rapidly expanding technological ecosystem — especially nanotechnology, ...
By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...
Merlin Egalite, co-founder of Morpho Labs, addressed the issue of temporary liquidity shortages in certain Morpho vaults on ...
A new physics study challenges the simulation hypothesis, arguing that the universe contains realities that can likely never ...
Janelia researchers have uncovered a novel way that two of the structures inside cells—the endoplasmic reticulum (ER) and ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...
SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...
SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...
The amygdala is part of the limbic system, which regulates emotional and behavioral responses. An amygdala hijack is a fight-or-flight response to stress. To better understand what an amygdala hijack ...